{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T22:23:47Z","timestamp":1743891827377,"version":"3.37.3"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,11,13]],"date-time":"2020-11-13T00:00:00Z","timestamp":1605225600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,11,13]],"date-time":"2020-11-13T00:00:00Z","timestamp":1605225600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1007\/s10549-020-06016-3","type":"journal-article","created":{"date-parts":[[2020,11,13]],"date-time":"2020-11-13T09:09:23Z","timestamp":1605258563000},"page":"561-568","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Relationship of circulating immune cells with lifestyle factors and cancer recurrence in early-stage breast cancer"],"prefix":"10.1007","volume":"186","author":[{"given":"Eric","family":"Xie","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maya M.","family":"Lapinski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Talamantes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bareng A. S.","family":"Nonyane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Cristina Figueroa","family":"Magalh\u00e3es","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kala","family":"Visvanathan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio C.","family":"Wolff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0979-8787","authenticated-orcid":false,"given":"Cesar A.","family":"Santa-Maria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,11,13]]},"reference":[{"issue":"10","key":"6016_CR1","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1001\/jamaoncol.2016.1061","volume":"2","author":"SE Stanton","year":"2016","unstructured":"Stanton SE, Adams S, Disis ML (2016) Variation in the incidence and magnitude of tumor-infiltrating lymphocytes in breast cancer subtypes: a systematic review. JAMA oncology 2(10):1354\u20131360","journal-title":"JAMA oncology"},{"issue":"1","key":"6016_CR2","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1186\/s12885-018-4888-2","volume":"18","author":"K Araki","year":"2018","unstructured":"Araki K, Ito Y, Fukada I, Kobayashi K, Miyagawa Y, Imamura M, Kira A, Takatsuka Y, Egawa C, Suwa H, Ohno S, Miyoshi Y (2018) Predictive impact of absolute lymphocyte counts for progression-free survival in human epidermal growth factor receptor 2-positive advanced breast cancer treated with pertuzumab and trastuzumab plus eribulin or nab-paclitaxel. BMC Cancer 18(1):982. https:\/\/doi.org\/10.1186\/s12885-018-4888-2","journal-title":"BMC Cancer"},{"key":"6016_CR3","doi-asserted-by":"publisher","first-page":"3371","DOI":"10.2147\/CMAR.S187233","volume":"11","author":"J Hong","year":"2019","unstructured":"Hong J, Chen X, Gao W, Zhu S, Wu J, Huang O, He J, Zhu L, Chen W, Li Y, Fei X, Lin L, Shen K (2019) A high absolute lymphocyte count predicts a poor prognosis in HER-2- positive breast cancer patients treated with trastuzumab. Cancer Manag Res 11:3371\u20133379. https:\/\/doi.org\/10.2147\/CMAR.S187233","journal-title":"Cancer Manag Res"},{"issue":"12","key":"6016_CR4","doi-asserted-by":"publisher","first-page":"2851","DOI":"10.1158\/1078-0432.CCR-17-1323","volume":"24","author":"A Afghahi","year":"2018","unstructured":"Afghahi A, Purington N, Han SS, Desai M, Pierson E, Mathur MB, Seto T, Thompson CA, Rigdon J, Telli ML, Badve SS, Curtis CN, West RB, Horst K, Gomez SL, Ford JM, Sledge GW, Kurian AW (2018) Higher Absolute Lymphocyte Counts Predict Lower Mortality from Early-Stage Triple-Negative Breast Cancer. Clinical cancer research\u202f: an official journal of the American Association for Cancer Research 24(12):2851\u20132858. https:\/\/doi.org\/10.1158\/1078-0432.CCR-17-1323","journal-title":"Clinical cancer research : an official journal of the American Association for Cancer Research"},{"issue":"16","key":"6016_CR5","doi-asserted-by":"publisher","first-page":"2784","DOI":"10.1200\/JCO.2009.25.6529","volume":"28","author":"ME Hammond","year":"2010","unstructured":"Hammond ME, Hayes DF, Dowsett M, Allred DC, Hagerty KL, Badve S, Fitzgibbons PL, Francis G, Goldstein NS, Hayes M, Hicks DG, Lester S, Love R, Mangu PB, McShane L, Miller K, Osborne CK, Paik S, Perlmutter J, Rhodes A, Sasano H, Schwartz JN, Sweep FC, Taube S, Torlakovic EE, Valenstein P, Viale G, Visscher D, Wheeler T, Williams RB, Wittliff JL, Wolff AC (2010) American Society of Clinical Oncology\/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. J Clin Oncol 28(16):2784\u20132795. https:\/\/doi.org\/10.1200\/JCO.2009.25.6529","journal-title":"J Clin Oncol"},{"issue":"31","key":"6016_CR6","doi-asserted-by":"publisher","first-page":"3997","DOI":"10.1200\/JCO.2013.50.9984","volume":"31","author":"Wolff AC, Hammond ME, Hicks DG, Dowsett M, McShane LM, Allison KH, Allred DC, Bartlett JM, Bilous M, Fitzgibbons P, Hanna W, Jenkins RB, Mangu PB, Paik S, Perez EA, Press MF, Spears PA, Vance GH, Viale G, Hayes DF, American Society of Clinical O, College of American P","year":"2013","unstructured":"Wolff AC, Hammond ME, Hicks DG, Dowsett M, McShane LM, Allison KH, Allred DC, Bartlett JM, Bilous M, Fitzgibbons P, Hanna W, Jenkins RB, Mangu PB, Paik S, Perez EA, Press MF, Spears PA, Vance GH, Viale G, Hayes DF, American Society of Clinical O, College of American P (2013) Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology\/College of American Pathologists clinical practice guideline update. J Clin Oncol 31(31):3997\u20134013. https:\/\/doi.org\/10.1200\/JCO.2013.50.9984","journal-title":"J Clin Oncol"},{"issue":"8","key":"6016_CR7","first-page":"410","volume":"32","author":"JY Sheng","year":"2018","unstructured":"Sheng JY, Sharma D, Jerome G, Santa-Maria CA (2018) Obese breast cancer patients and survivors: Management considerations. Breast Cancer 32(8):410\u2013417","journal-title":"Breast Cancer"},{"key":"6016_CR8","doi-asserted-by":"publisher","first-page":"643","DOI":"10.3389\/fimmu.2017.00643","volume":"8","author":"G Donninelli","year":"2017","unstructured":"Donninelli G, Del Corn\u00f2 M, Pierdominici M, Scazzocchio B, Var\u00ec R, Varano B, Pacella I, Piconese S, Barnaba V, D\u2019Archivio MJFii, (2017) Distinct blood and visceral adipose tissue regulatory T cell and innate lymphocyte profiles characterize obesity and colorectal cancer. Front Immunol 8:643","journal-title":"Front Immunol"},{"key":"6016_CR9","doi-asserted-by":"publisher","first-page":"2556","DOI":"10.3389\/fimmu.2018.02556","volume":"9","author":"M Del Corn\u00f2","year":"2018","unstructured":"Del Corn\u00f2 M, Conti L, Gessani S (2018) Innate Lymphocytes in Adipose Tissue Homeostasis and Their Alterations in Obesity and Colorectal Cancer. Front Immunol 9:2556\u20132556. https:\/\/doi.org\/10.3389\/fimmu.2018.02556","journal-title":"Front Immunol"},{"issue":"21","key":"6016_CR10","doi-asserted-by":"publisher","first-page":"e10759","DOI":"10.1097\/MD.0000000000010759","volume":"97","author":"Z Li","year":"2018","unstructured":"Li Z, Xu Z, Huang Y, Zhao R, Cui Y, Zhou Y, Wu X (2018) The predictive value and the correlation of peripheral absolute monocyte count, tumor-associated macrophage and microvessel density in patients with colon cancer. Medicine (Baltimore) 97(21):e10759\u2013e10759. https:\/\/doi.org\/10.1097\/MD.0000000000010759","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"6016_CR11","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s12876-018-0877-9","volume":"18","author":"F Feng","year":"2018","unstructured":"Feng F, Zheng G, Wang Q, Liu S, Liu Z, Xu G, Wang F, Guo M, Lian X, Zhang H (2018) Low lymphocyte count and high monocyte count predicts poor prognosis of gastric cancer. BMC Gastroenterol 18(1):148\u2013148. https:\/\/doi.org\/10.1186\/s12876-018-0877-9","journal-title":"BMC Gastroenterol"},{"issue":"7","key":"6016_CR12","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1111\/dote.12401","volume":"29","author":"L Han","year":"2016","unstructured":"Han L, Jia Y, Song Q, Wang N, Wang J, Bai B, Chen X, Wang C, Cheng Y (2016) Prognostic significance of preoperative absolute peripheral monocyte count in esophageal squamous cell carcinoma. Dis Esophagus 29(7):740\u2013746. https:\/\/doi.org\/10.1111\/dote.12401","journal-title":"Dis Esophagus"},{"issue":"49","key":"6016_CR13","doi-asserted-by":"publisher","first-page":"e2266","DOI":"10.1097\/MD.0000000000002266","volume":"94","author":"J Wen","year":"2015","unstructured":"Wen J, Ye F, Huang X, Li S, Yang L, Xiao X, Xie X (2015) Prognostic Significance of Preoperative Circulating Monocyte Count in Patients With Breast Cancer: Based on a Large Cohort Study. Medicine (Baltimore) 94(49):e2266\u2013e2266. https:\/\/doi.org\/10.1097\/MD.0000000000002266","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"6016_CR14","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1093\/oxfordjournals.aje.a116601","volume":"137","author":"R Olivares","year":"1993","unstructured":"Olivares R, Ducimetiere P, Claude JR (1993) Monocyte count: a risk factor for coronary heart disease? Am J Epidemiol 137(1):49\u201353. https:\/\/doi.org\/10.1093\/oxfordjournals.aje.a116601","journal-title":"Am J Epidemiol"},{"issue":"1","key":"6016_CR15","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s13058-015-0621-0","volume":"17","author":"S Sousa","year":"2015","unstructured":"Sousa S, Brion R, Lintunen M, Kronqvist P, Sandholm J, M\u00f6nkk\u00f6nen J, Kellokumpu-Lehtinen P-L, Lauttia S, Tynninen O, Joensuu H (2015) Human breast cancer cells educate macrophages toward the M2 activation status. Breast Cancer Res 17(1):101","journal-title":"Breast Cancer Res"},{"issue":"6","key":"6016_CR16","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/j.ejca.2006.01.003","volume":"42","author":"A Sica","year":"2006","unstructured":"Sica A, Schioppa T, Mantovani A, Allavena P (2006) Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy. Eur J Cancer 42(6):717\u2013727","journal-title":"Eur J Cancer"},{"issue":"21","key":"6016_CR17","doi-asserted-by":"publisher","first-page":"4111","DOI":"10.1007\/s00018-015-1995-y","volume":"72","author":"A Sica","year":"2015","unstructured":"Sica A, Erreni M, Allavena P, Porta C (2015) Macrophage polarization in pathology. Cell Mol Life Sci 72(21):4111\u20134126. https:\/\/doi.org\/10.1007\/s00018-015-1995-y","journal-title":"Cell Mol Life Sci"},{"key":"6016_CR18","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.imlet.2016.06.001","volume":"176","author":"I Torres-Castro","year":"2016","unstructured":"Torres-Castro I, Arroyo-Camarena \u00daD, Mart\u00ednez-Reyes CP, G\u00f3mez-Arauz AY, Due\u00f1as-Andrade Y, Hern\u00e1ndez-Ruiz J, B\u00e9jar YL, Zaga-Clavellina V, Morales-Montor J, Terrazas LI (2016) Human monocytes and macrophages undergo M1-type inflammatory polarization in response to high levels of glucose. Immunol Lett 176:81\u201389","journal-title":"Immunol Lett"},{"issue":"8","key":"6016_CR19","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1007\/s00125-013-2918-9","volume":"56","author":"G Fadini","year":"2013","unstructured":"Fadini G, de Kreutzenberg SV, Boscaro E, Albiero M, Cappellari R, Kr\u00e4nkel N, Landmesser U, Toniolo A, Bolego C, Cignarella A (2013) An unbalanced monocyte polarisation in peripheral blood and bone marrow of patients with type 2 diabetes has an impact on microangiopathy. Diabetologia 56(8):1856\u20131866","journal-title":"Diabetologia"},{"issue":"1","key":"6016_CR20","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1074\/jbc.M115.694133","volume":"291","author":"B Saha","year":"2016","unstructured":"Saha B, Momen-Heravi F, Kodys K, Szabo G (2016) MicroRNA cargo of extracellular vesicles from alcohol-exposed monocytes signals naive monocytes to differentiate into M2 macrophages. J Biol Chem 291(1):149\u2013159","journal-title":"J Biol Chem"},{"issue":"29","key":"6016_CR21","doi-asserted-by":"publisher","first-page":"4410","DOI":"10.1200\/JCO.2010.29.2730","volume":"28","author":"ML Kwan","year":"2010","unstructured":"Kwan ML, Kushi LH, Weltzien E, Tam EK, Castillo A, Sweeney C, Caan BJJJocO (2010) Alcohol consumption and breast cancer recurrence and survival among women with early-stage breast cancer: the life after cancer epidemiology study. J Clin Oncol 28(29):4410","journal-title":"J Clin Oncol"},{"issue":"69","key":"6016_CR22","doi-asserted-by":"publisher","first-page":"114268","DOI":"10.18632\/oncotarget.23217","volume":"8","author":"A Diehl","year":"2017","unstructured":"Diehl A, Yarchoan M, Hopkins A, Jaffee E, Grossman SAJO (2017) Relationships between lymphocyte counts and treatment-related toxicities and clinical responses in patients with solid tumors treated with PD-1 checkpoint inhibitors. Oncotarget 8(69):114268","journal-title":"Oncotarget"},{"key":"6016_CR23","doi-asserted-by":"publisher","first-page":"34310","DOI":"10.1038\/srep34310","volume":"6","author":"WH Yeap","year":"2016","unstructured":"Yeap WH, Wong KL, Shimasaki N, Teo EC, Quek JK, Yong HX, Diong CP, Bertoletti A, Linn YC, Wong SC (2016) CD16 is indispensable for antibody-dependent cellular cytotoxicity by human monocytes. Sci Rep 6:34310. https:\/\/doi.org\/10.1038\/srep34310","journal-title":"Sci Rep"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-020-06016-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-020-06016-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-020-06016-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,24]],"date-time":"2021-03-24T17:23:57Z","timestamp":1616606637000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-020-06016-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,13]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["6016"],"URL":"https:\/\/doi.org\/10.1007\/s10549-020-06016-3","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"type":"print","value":"0167-6806"},{"type":"electronic","value":"1573-7217"}],"subject":[],"published":{"date-parts":[[2020,11,13]]},"assertion":[{"value":"26 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"CAS has research funding from Pfizer, Astra Zeneca, Tesaro, and Novartis; has served on advisory boards for Bristol Meyers Squibb, Genomic Health, Athenex, Polyphor, and Halozyme. MCFM has received speaker\u2019s compensation from Novartis, Lilly, and Boehringer Ingelheim. KV is an inventor on one or more patents applied for on issues relating to methylation and cancer in the past 5\u00a0years and has assigned her rights to her institution, and participates in a royalty-sharing agreement with her institution. The other authors have no conflicts to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}